Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Discontinuation Study of XL184 in Subjects With Advanced Solid Tumors

NCT00940225 is registered in ClinicalTrials.gov with Exelixis as lead sponsor.

NCT NCT00940225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00940225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Discontinuation Study of XL184 in Subjects With Advanced Solid Tumors
Lead sponsor
Exelixis
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2009
Completion date
June 30, 2014
Enrollment
730 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, solid tumors